Revium Rx.
RVRC· OTC
RVRCRevium Rx.
Filed Aug 13, 2026 · 10-Q · 44 days after period end · 0001213900-26-089070
| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Net Income | -$748.00K | -$1.04M |
| EPS Diluted | $0.01 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Revium Rx. · CIK 1839140 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end
